Bsamat Shifa – Medical Limited Company Organizes Pharmacovigilance and Drug Safety Conference
Bsamat Shifa – Medical Limited Company organized an awareness conference titled “Pharmacovigilance and Drug Safety Conference,” reaffirming its commitment to promoting pharmaceutical quality and strengthening a culture of drug safety within the healthcare sector.
The conference brought together experts and specialists from pharmaceutical, healthcare, and academic sectors to discuss the latest practices and regulatory frameworks in pharmacovigilance, as well as modern systems for monitoring adverse drug reactions and ensuring safe medication use.
Key topics discussed during the conference included:
- Adverse event monitoring systems and the role of healthcare institutions in effective reporting.
- International safety standards and regulatory compliance in pharmaceutical practice.
- The importance of robust safety databases for signal detection and risk management.
- Challenges facing pharmacovigilance systems in emerging markets and strategies for improvement.
The event also emphasized the importance of collaboration between pharmaceutical companies, regulatory authorities, and healthcare providers to enhance data collection, analysis, and risk mitigation processes.
Company representatives highlighted that organizing this conference aligns with their strategic objective of fostering a safe and compliant pharmaceutical environment while strengthening cooperation among stakeholders to protect public health.
The conference concluded with an interactive discussion session, allowing participants to exchange insights and propose actionable recommendations for advancing pharmacovigilance systems and reinforcing drug safety practices.